In recent years, cannabis has risen as one of the most talked-about potential medical treatments for all kinds of diseases and ailments. Though undoubtedly much more research needs to be done to properly determine its true level of effectiveness, it’s still becoming more and more popular around the world and is generally accepted to at least have possible medicinal properties that could impact how we care for cancer patients, those suffering from PTSD, people living with epilepsy, anxiety and more.
Many people are unaware that the final product of cannabis is a pharmaceutical and treated as an active pharmaceutical ingredient (API). As someone who has worked in the life sciences consulting sector for over 20 years, I can tell you that it doesn’t change anything from a regulatory standpoint and procedure. The laws, be it FDA, EMEA or HRA, have stayed the same for many years, but the techniques for interpreting them have changed.
– Read the entire article at Forbes.
Original Article
